1st Quarter - Report

FOUNDATION MEDICINE, INC. for FOUNDATION MEDICINE, INC.

Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S.1895, Lower Health Care Costs Act," Section 401, regarding hospital billing practices H.R. 2328, Reauthorizing and Extending Americas Community Health Act, Title IV, regarding hospital billing practices H.R. 5826, Consumer Protections Against Surprise Medical Bills Act of 2020, regarding surprise medical billing FDA regulatory policy generally and policy for approval of new oncology diagnostic technologies S.3404/H.R.6102, VALID Act of 2020, all provisions

LobbyistCovered position, as disclosed
JENNIFER ROMANS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1895 (116th), S. 3404 (116th), H.R. 5826 (116th), H.R. 2328 (116th), H.R. 6102 (116th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
ROCHE FINANCE LTD. Switzerland Switzerland 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.